These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 11751767)

  • 1. Molecular epidemiology and evolution of resistance to quinolones in Escherichia coli after prolonged administration of ciprofloxacin in patients with prostatitis.
    Horcajada JP; Vila J; Moreno-Martínez A; Ruiz J; Martínez JA; Sánchez M; Soriano E; Mensa J
    J Antimicrob Chemother; 2002 Jan; 49(1):55-9. PubMed ID: 11751767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of mutation and combating the evolution of antibiotic resistance.
    Cirz RT; Chin JK; Andes DR; de Crécy-Lagard V; Craig WA; Romesberg FE
    PLoS Biol; 2005 Jun; 3(6):e176. PubMed ID: 15869329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A spatial approach for the epidemiology of antibiotic use and resistance in community-based studies: the emergence of urban clusters of Escherichia coli quinolone resistance in Sao Paulo, Brasil.
    Kiffer CR; Camargo EC; Shimakura SE; Ribeiro PJ; Bailey TC; Pignatari AC; Monteiro AM
    Int J Health Geogr; 2011 Feb; 10():17. PubMed ID: 21356088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular Response to Ciprofloxacin in Low-Level Quinolone-Resistant
    Machuca J; Recacha E; Briales A; Díaz-de-Alba P; Blazquez J; Pascual Á; Rodríguez-Martínez JM
    Front Microbiol; 2017; 8():1370. PubMed ID: 28769919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluoroquinolone resistance in urinary tract infections: Epidemiology, mechanisms of action and management strategies.
    Thompson D; Xu J; Ischia J; Bolton D
    BJUI Compass; 2024 Jan; 5(1):5-11. PubMed ID: 38179021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Perfect Condition for the Rising of Superbugs: Person-to-Person Contact and Antibiotic Use Are the Key Factors Responsible for the Positive Correlation between Antibiotic Resistance Gene Diversity and Virulence Gene Diversity in Human Metagenomes.
    Domingues CPF; Rebelo JS; Pothier J; Monteiro F; Nogueira T; Dionisio F
    Antibiotics (Basel); 2021 May; 10(5):. PubMed ID: 34065307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transferable Mechanisms of Quinolone Resistance from 1998 Onward.
    Ruiz J
    Clin Microbiol Rev; 2019 Sep; 32(4):. PubMed ID: 31413045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of multidrug-resistant organisms in refugee patients admitted to a German university hospital depending on duration of stay in Germany.
    Reinheimer C; Abdollahi P; Zacharowski K; Meybohm P; Mutlak H; Klingebiel T; Wichelhaus TA; Kempf VAJ
    GMS Hyg Infect Control; 2019; 14():Doc07. PubMed ID: 31293878
    [No Abstract]   [Full Text] [Related]  

  • 9. Impact of extensive antibiotic treatment on faecal carriage of antibiotic-resistant enterobacteria in children in a low resistance prevalence setting.
    Knudsen PK; Brandtzaeg P; Høiby EA; Bohlin J; Samuelsen Ø; Steinbakk M; Abrahamsen TG; Müller F; Gammelsrud KW
    PLoS One; 2017; 12(11):e0187618. PubMed ID: 29112974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence, Risk Factors, and Clinical Relevance of Fluoroquinolone-Resistant Organisms in Rectal Cultures: Should We Target Antibiotic Prophylaxis Prior to Prostate Biopsy?
    Van Besien J; Uvin P; Van den Abeele AM; Merckx L
    Adv Urol; 2016; 2016():5392107. PubMed ID: 27034660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of antibiotic-resistant bacteria on rectal swabs and factors affecting resistance to antibiotics in patients undergoing prostate biopsy.
    Kim JB; Jung SI; Hwang EC; Kwon DD
    Korean J Urol; 2014 Mar; 55(3):201-6. PubMed ID: 24648876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening rectal culture to identify fluoroquinolone-resistant organisms before transrectal prostate biopsy: do the culture results between office visit and biopsy correlate?
    Liss MA; Nakamura KK; Meuleners R; Kolla SB; Dash A; Peterson EM
    Urology; 2013 Jul; 82(1):67-71. PubMed ID: 23806391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistence of ultrasound alterations after antibiotic treatment with levofloxacin in patients with male accessory gland infection.
    La Vignera S; Condorelli RA; Calogero AE; Bellanca S; Salmeri M; Vicari E
    Asian J Androl; 2012 Nov; 14(6):879-83. PubMed ID: 23064686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of fluoroquinolone resistance through successful regulation, Australia.
    Cheng AC; Turnidge J; Collignon P; Looke D; Barton M; Gottlieb T
    Emerg Infect Dis; 2012 Sep; 18(9):1453-60. PubMed ID: 22932272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged carriage of resistant E. coli by returned travellers: clonality, risk factors and bacterial characteristics.
    Rogers BA; Kennedy KJ; Sidjabat HE; Jones M; Collignon P; Paterson DL
    Eur J Clin Microbiol Infect Dis; 2012 Sep; 31(9):2413-20. PubMed ID: 22391758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and risk factors for quinolone resistance among Escherichia coli strains isolated from males with community febrile urinary tract infection.
    Smithson A; Chico C; Ramos J; Netto C; Sanchez M; Ruiz J; Porron R; Bastida MT
    Eur J Clin Microbiol Infect Dis; 2012 Apr; 31(4):423-30. PubMed ID: 21761126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluoroquinolone-resistant acute prostatitis requiring hospitalization after transrectal prostate biopsy: effect of previous fluoroquinolone use as prophylaxis or long-term treatment.
    Ekici S; Cengiz M; Turan G; Alış EE
    Int Urol Nephrol; 2012 Feb; 44(1):19-27. PubMed ID: 21547465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergence and acquisition of fluoroquinolone-resistant gram-negative bacilli in the intestinal tracts of mice treated with fluoroquinolone antimicrobial agents.
    Pultz MJ; Nerandzic MM; Stiefel U; Donskey CJ
    Antimicrob Agents Chemother; 2008 Sep; 52(9):3457-60. PubMed ID: 18606843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duration of outpatient fecal colonization due to Escherichia coli Isolates with decreased susceptibility to fluoroquinolones: longitudinal study of patients recently discharged from the hospital.
    Lautenbach E; Tolomeo P; Mao X; Fishman NO; Metlay JP; Bilker WB; Nachamkin I
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3939-43. PubMed ID: 16982789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors influencing fluoroquinolone resistance.
    Sahm DF; Thornsberry C; Jones ME; Karlowsky JA
    Emerg Infect Dis; 2003 Dec; 9(12):1651-4. PubMed ID: 14725310
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.